Homeodomain-interacting protein kinase-2 (HIPK2) phosphorylates HMGA1a at Ser-35, Thr-52, and Thr-77 and modulates its DNA binding affinity

Journal of Proteome Research

Volumn 6, Issue 12, 2007, Pages 4711-4719

  Zhang, Qingchun ^a   Wang, Yinsheng ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cdc2; DNA binding; HIPK2; HMGA; Phosphorylation; Proline directed kinase

Indexed keywords

HIGH MOBILITY GROUP A1A PROTEIN; HOMEODOMAIN INTERACTING PROTEIN KINASE 2; SERINE; THREONINE;

ARTICLE; BINDING AFFINITY; CELL CYCLE; DNA BINDING; GERM LINE; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

AMINO ACID SEQUENCE; CARRIER PROTEINS; CDC2 PROTEIN KINASE; DNA; HMGA1A PROTEIN; HMGA1B PROTEIN; HUMANS; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN ISOFORMS; PROTEIN-SERINE-THREONINE KINASES; SERINE; THREONINE;

EUKARYOTA;

EID: 38049037736     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr700571d     Document Type: Article

References (75)

1. Bustin, M.; Reeves, R. High-mobility-group chromosomal proteins: architectural components that facilitate chromatin function. Prog. Nucleic Acid 0Res. Mol. Biol. 1996, 54, 35-100.
2. Sgarra, R.; Rustighi, A.; Tessari, M. A.; Di Bernardo, J.; Altamura, S.; Fusco, A.; Manfioletti, G.; Giancotti, V. Nuclear phosphoproteins HMGA and their relationship with chromatin structure and cancer. FEBS Lett. 2004, 574, 1-8.
3. Reeves, R. Molecular biology of HMGA proteins: hubs of nuclear function. Gene 2001, 277, 63-81.
4. Fedele, M.; Bandiera, A.; Chiappetta, G.; Battista, S.; Viglietto, G.; Manfioletti, G.; Casamassimi, A.; Santoro, M.; Giancotti, V.; Fusco, A. Human colorectal carcinomas express high levels of high mobility group HMGI(Y) proteins. Cancer Res. 1996, 56, 1896-1901.
5. Bandiera, A.; Bonifacio, D.; Manfioletti, G.; Mantovani, F.; Rustighi, A.; Zanconati, F.; Fusco, A.; Di Bonito, L.; Giancotti, V. Expression of HMGI(Y) proteins in squamous intraepithelial and invasive lesions of the uterine cervix. Cancer Res. 1998, 58, 426-431.
6. Chiappetta, G.; Tallini, G.; De Biasio, M. G.; Manfioletti, G.; Martinez-Tello, F. J.; Pentimalli, F.; de Nigris, F.; Mastro, A.; Botti, G.; Fedele, M.; Berger, N.; Santoro, M.; Giancotti, V.; Fusco, A. Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma. Cancer Res. 1998, 58, 4193-4198.
7. Johnson, K. R.; Lehn, D. A.; Elton, T. S.; Barr, P. J.; Reeves, R. Complete murine cDNA sequence, genomic structure, and tissue expression of the high mobility group protein HMG-I(Y). J. Biol. Chem. 1988, 263, 18338-18342.
8. Johnson, K. R.; Lehn, D. A.; Reeves, R. Alternative processing of mRNAs encoding mammalian chromosomal high-mobility-group proteins HMG-I and HMG-Y. Mol. Cell. Biol. 1989, 9, 2114-2123.
9. Strauss, F.; Varshavsky, A. A protein binds to a satellite DNA repeat at three specific sites that would be brought into mutual proximity by DNA folding in the nucleosome. Cell 1984, 37, 889-901.
10. Solomon, M. J.; Strauss, F.; Varshavsky, A. A mammalian high mobility group protein recognizes any stretch of six A.T base pairs in duplex DNA. Proc. Natl. Acad. Sci. U.S.A. 1986, 83, 1276-1280.
11. Reeves, R.; Nissen, M. S. The A.T-DNA-binding domain of mammalian high mobility group I chromosomal proteins. A novel peptide motif for recognizing DNA structure. J. Biol. Chem. 1990, 265, 8573-8582.
12. Reeves, R.; Elton, T. S.; Nissen, M. S.; Lehn, D.; Johnson, K. R. Posttranscriptional gene regulation and specific binding of the nonhistone protein HMG-I by the 3′ untranslated region of bovine interleukin 2 cDNA. Proc. Natl. Acad. Sci. U.S.A. 1987, 84, 6531-6535.
13. Maher, J. F.; Nathans, D. Multivalent DNA-binding properties of the HMG-1 proteins. Proc. Natl. Acad. Sci. U.S.A. 1996, 93, 6716-6720.
14. Reeves, R.; Beckerbauer, L. HMGI/Y proteins: flexible regulators of transcription and chromatin structure. Biochim. Biophys. Acta 2001, 1519, 13-29.
15. Harrer, M.; Luhrs, H.; Bustin, M.; Scheer, U.; Hock, R. Dynamic interaction of HMGA1a proteins with chromatin. J. Cell Sci. 2004, 117, 3459-3471.
16. Huth, J. R.; Bewley, C. A.; Nissen, M. S.; Evans, J. N.; Reeves, R.; Gronenborn, A. M.; Gore, G. M. The solution structure of an HMG-I(Y)-DNA complex defines a new architectural minor groove binding motif. Nat. Struct. Biol. 1997, 4, 657-665.
17. Sgarra, R.; Tessari, M. A.; Di Bernardo, J.; Rustighi, A.; Zago, P.; Liberatori, S.; Armini, A.; Bini, L.; Giancotti, V.; Manfioletti, G. Discovering high mobility group A molecular partners in tumour cells. Proteomics 2005, 5, 1494-1506.
18. Frasca, F.; Rustighi, A.; Malaguarnera, R.; Altamura, S.; Vigneri, P.; Del Sal, G.; Giancotti, V.; Pezzino, V.; Vigneri, R.; Manfioletti, G. HMGA1 inhibits the function of p53 family members in thyroid cancer cells. Cancer Res. 2006, 66, 2980-2989.
19. Munshi, N.; Agalioti, T.; Lomvardas, S.; Merika, M.; Chen, G.; Thanos, D. Coordination of a transcriptional switch by HMGI(Y) acetylation. Science 2001, 293, 1133-1136.
20. Munshi, N.; Merika, M.; Yie, J.; Senger, K.; Chen, G.; Thanos, D. Acetylation of HMG I(Y) by CBP turns off IFN beta expression by disrupting the enhanceosome. Mol. Cell 1998, 2, 457-467.
21. Jiang, X.; Wang, Y. Acetylation and phosphorylation of high-mobility group A1 proteins in PC-3 human tumor cells. Biochemistry 2006, 45, 7194-7201.
22. Zhang, Q.; Zhang, K.; Zou, Y.; Perna, A.; Wang, Y. A quantitative study on the in-vitro and in-vivo acetylation of high mobility group A1 proteins. J. Am. Soc. Mass Spectrom. 2007, 18, 1569-1578.
23. Sgarra, R.; Diana, F.; Bellarosa, C.; Dekleva, V.; Rustighi, A.; Toller, M.; Manfioletti, G.; Giancotti, V. During apoptosis of tumor cells HMGA1a protein undergoes methylation: identification of the modification site by mass spectrometry. Biochemistry 2003, 42, 3575-3585.
24. Sgarra, R.; Diana, F.; Rustighi, A.; Manfioletti, G.; Giancotti, V. Increase of HMGA1a protein methylation is a distinctive characteristic of leukaemic cells induced to undergo apoptosis. Cell Death Differ. 2003, 10, 386-389.
25. Sgarra, R.; Lee, J.; Tessari, M. A.; Altamura, S.; Spolaore, B.; Giancotti, V.; Bedford, M. T.; Manfioletti, G. The AT-hook of the chromatin architectural transcription factor high mobility group A1a is arginine-methylated by protein arginine methyltransferase 6. J. Biol. Chem. 2006, 281, 3764-3772.
26. Zou, Y.; Wang, Y. Tandem mass spectrometry for the examination of the posttranslational modifications of high-mobility group A1 proteins: symmetric and asymmetric dimethylation of Arg25 in HMGA1a protein. Biochemistry 2005, 44, 6293-6301.
27. Zou, Y.; Webb, K.; Perna, A. D.; Zhang, Q.; Clarke, S.; Wang, Y. A mass spectrometric study on the in vitro methylation of HMGA1a and HMGA1b proteins by PRMTs: methylation specificity, the effect of binding to AT-rich duplex DNA, and the effect of C-terminal phosphorylation. Biochemistry 2007, 46, 7896-7906.
28. Zou, Y.; Wang, Y. Mass spectrometric analysis of high-mobility group proteins and their post-translational modifications in normal and cancerous human breast tissues. J. Proteome Res. 2007, 6, 2304-2314.
29. Elton, T. S.; Reeves, R. Purification and postsynthetic modifications of Friend erythroleukemic cell high mobility group protein HMG-I. Anal. Biochem. 1986, 157, 53-62.
30. Lund, T.; Holtlund, J.; Laland, S. G. On the phosphorylation of low molecular mass HMG high mobility group) proteins in Ehrlich ascites cells. FEBS Lett. 1985, 180, 275-279.
31. Diana, F.; Sgarra, R.; Manfioletti, G.; Rustighi, A.; Poletto, D.; Sciortino, M. T.; Mastino, A.; Giancotti, V. A link between apoptosis and degree of phosphorylation of high mobility group A1a protein in leukemic cells. J. Biol. Chem. 2001, 276, 11354-11361.
32. Reeves, R.; Langan, T. A.; Nissen, M. S. Phosphorylation of the DNA-binding domain of nonhistone high-mobility group I protein by cdc2 kinase: reduction of binding affinity. Proc. Natl. Acad. Sci. U.S.A. 1991, 88, 1671-1675.
33. Lund, T.; Laland, S. G. The metaphase specific phosphorylation of HMG I. Biochem. Biophys. Res. Commun. 1990, 171, 342-347.
34. Xiao, D. M.; Pak, J. H.; Wang, X.; Sato, T.; Huang, F. L.; Chen, H. C.; Huang, K. P. Phosphorylation of HMG-I by protein kinase C attenuates its binding affinity to the promoter regions of protein kinase C gamma and neurogranin/RC3 genes. J. Neurochem. 2000, 74, 392-399.
35. Palvimo, J.; Linnala-Kankkunen, A. Identification of sites on chromosomal protein HMG-I phosphorylated by casein kinase II. FEBS Lett. 1989, 257, 101-104.
36. Ferranti, P.; Malorni, A.; Marino, G.; Pucci, P.; Goodwin, G. H.; Manfioletti, G.; Giancotti, V. Mass spectrometric analysis of the HMGY protein from Lewis lung carcinoma. Identification of phosphorylation sites. J. Biol. Chem. 1992, 267, 22486-22489.
37. Wang, D. Z.; Ray, P.; Boothby, M. Interleukin 4-inducible phosphorylation of HMG-I(Y) is inhibited by rapamycin. J. Biol. Chem. 1995, 270, 22924-22932.
38. Wisniewski, J. R.; Szewczuk, Z.; Petry, I.; Schwanbeck, R.; Renner, U. Constitutive phosphorylation of the acidic tails of the high mobility group 1 proteins by casein kinase II alters their conformation, stability, and DNA binding specificity. J. Biol. Chem. 1999, 274, 20116-20122.
39. Schwanbeck, R.; Gymnopoulos, M.; Petry, I.; Piekielko, A.; Szewczuk, Z.; Heyduk, T.; Zechel, K.; Wisniewski, J. R. Consecutive steps of phosphorylation affect conformation and DNA binding of the chironomus high mobility group A protein. J. Biol. Chem. 2001, 276, 26012-26021.
40. Piekielko, A.; Drung, A.; Rogalla, P.; Schwanbeck, R.; Heyduk, T.; Gerharz, M.; Bullerdiek, J.; Wisniewski, J. R. Distinct organization of DNA complexes of various HMGI/Y family proteins and their modulation upon mitotic phosphorylation. J. Biol. Chem. 2001, 276, 1984-1992.
41. Nissen, M. S.; Langan, T. A.; Reeves, R. Phosphorylation by cdc2 kinase modulates DNA binding activity of high mobility group I nonhistone chromatin protein. J. Biol. Chem. 1991, 266, 19945-19952.
42. Hofmann, T. G.; Mincheva, A.; Lichter, P.; Droge, W.; Schmitz, M. L. Human homeodomain-interacting protein kinase-2 (HIPK2) is a member of the DYRK family of protein kinases and maps to chromosome 7q32-q34. Biochimie 2000, 82, 1123-1127.
43. Kim, Y. H.; Choi, C. Y.; Lee, S. J.; Conti, M. A.; Kim, Y. Homeodomain-interacting protein kinases, a novel family of co-repressors for homeodomain transcription factors. J. Biol. Chem. 1998, 273, 25875-25879.
44. D'Orazi, G.; Cecchinelli, B.; Bruno, T.; Manni, I.; Higashimoto, Y.; Saito, S.; Gostissa, M.; Coen, S.; Marchetti, A.; Del Sal, G.; Piaggio, G.; Fanciulli, M.; Appella, E.; Soddu, S. Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis. Nat. Cell Biol. 2002, 4, 11-19.
45. Hofmann, T. G.; Moller, A.; Sirma, H.; Zentgraf, H.; Taya, Y.; Droge, W.; Will, H.; Schmitz, M. L. Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2. Nat. Cell Biol. 2002, 4, 1-10.
46. Di Stefano, V.; Blandino, G.; Sacchi, A.; Soddu, S.; D'Orazi, G. HIPK2 neutralizes MDM2 inhibition rescuing p53 transcriptional activity and apoptotic function. Oncogene 2004, 23, 5185-5192.
47. Di Stefano, V.; Rinaldo, C.; Sacchi, A.; Soddu, S.; D'Orazi, G. Homeodomain-interacting protein kinase-2 activity and p53 phosphorylation are critical events for cisplatin-mediated apoptosis. Exp. Cell Res. 2004, 293, 311-320.
48. Dauth, I.; Kruger, J.; Hofmann, T. G. Homeodomain-interacting protein kinase 2 is the ionizing radiation-activated p53 serine 46 kinase and is regulated by ATM. Cancer Res. 2007, 67, 2274-2279.
49. Cecchinelli, B.; Porrello, A.; Lazzari, C.; Gradi, A.; Bossi, G.; D'Angelo, M.; Sacchi, A.; Soddu, S. Ser58 of mouse p53 is the homologue of human Ser46 and is phosphorylated by HIPK2 in apoptosis. Cell Death Differ. 2006, 13, 1994-1997.
50. Di Stefano, V.; Soddu, S.; Sacchi, A.; D'Orazi, G. HIPK2 contributes to PCAF-mediated p53 acetylation and selective transactivation of p21Waf1 after nonapoptotic DNA damage. Oncogene 2005, 24, 5431-5442.
51. Kim, E. A.; Noh, Y. T.; Ryu, M. J.; Kim, H. T.; Lee, S. E.; Kim, C. H.; Lee, C.; Kim, Y. H.; Choi, C. Y. Phosphorylation and transactivation of Pax6 by homeodomain-interacting protein kinase 2. J. Biol. Chem. 2006, 281, 7489-7497.
52. Pierantoni, G. M.; Fedele, M.; Pentimalli, F.; Benvenuto, G.; Pero, R.; Viglietto, G.; Santoro, M.; Chiariotti, L.; Fusco, A. High mobility group I (Y) proteins bind HIPK2, a serine-threonine kinase protein which inhibits cell growth. Oncogene 2001, 20, 6132-6141.
53. Reeves, R. HMGA proteins: isolation, biochemical modifications, and nucleosome interactions. Methods Enzymol. 2004, 375, 297-322.
54. Tholey, A.; Reed, J.; Lehmann, W. D. Electrospray tandem mass spectrometric studies of phosphopeptides and phosphopeptide analogues. J. Mass Spectrom. 1999, 34, 117-123.
55. DeGnore, J. P.; Qin, J. Fragmentation of phosphopeptides in an ion trap mass spectrometer. J. Am. Soc. Mass Spectrom. 1998, 9, 1175-1188.
56. Moyer, S. C.; Cotter, R. J.; Woods, A. S. Fragmentation of phosphopeptides by atmospheric pressure MALDI and ESI/Ion trap mass spectrometry. J. Am. Soc. Mass Spectrom. 2002, 13, 274-283.
57. Lehmann, W. D.; Kruger, R.; Salek, M.; Hung, C. W.; Wolschin, F.; Weckwerth, W. Neutral loss-based phosphopeptide recognition: a collection of caveats. J. Proteome Res. 2007, 6, 2866-2873.
58. Leitner, A.; Foettinger, A.; Lindner, W. Improving fragmentation of poorly fragmenting peptides and phosphopeptides during collision-induced dissociation by malondialdehyde modification of arginine residues. J. Mass Spectrom. 2007, 42, 950-959.
59. Bashir, T.; Pagano, M. Cdk1: the dominant sibling of Cdk2. Nat. Cell Biol. 2005, 7, 779-781.
60. cdc2 regulation. Mol. Cell. Biol. 1993, 13, 1675-1685.
61. cdc2: in vivo Veritas? Cell 1990, 61, 549-551.
62. Gao, Y.; Wang, Y. A method to determine the ionization efficiency change of peptides caused by phosphorylation. J. Am. Soc. Mass Spectrom., 2007 [Online early access]. DOI: 10.1016/j.jasms. 2007.08.010. Published Online: Aug 22, 2007.
63. Giancotti, V.; Pani, B.; D'Andrea, P.; Berlingieri, M. T.; Di Fiore, P. P.; Fusco, A.; Vecchio, G.; Philp, R.; Crane-Robinson, C.; Nicolas, R. H. Elevated levels of a specific class of nuclear phosphoproteins in cells transformed with v-ras and v-mos oncogenes and by cotransfection with c-myc and polyoma middle T genes. EMBO J. 1987, 6, 1981-1987.
64. Pierantoni, G. M.; Bulfone, A.; Pentimalli, F.; Fedele, M.; Iuliano, R.; Santoro, M.; Chiariotti, L.; Ballabio, A.; Fusco, A. The homeodomain-interacting protein kinase 2 gene is expressed late in embryogenesis and preferentially in retina, muscle, and neural tissues. Biochem. Biophys. Res. Commun. 2002, 290, 942-947.
65. Pearson, R. B.; Kemp, B. E. Protein kinase phosphorylation site sequences and consensus specificity motifs: tabulations. Methods Enzymol. 1991, 200, 62-81.
66. Hall, F. L.; Vulliet, P. R. Proline-directed protein phosphorylation and cell cycle regulation. Curr. Opin. Cell Biol. 1991, 3, 176-184.
67. Lu, K. P.; Liou, Y. C.; Zhou, X. Z. Pinning down proline-directed phosphorylation signaling. Trends Cell Biol. 2002, 12, 164-172.
68. Wesierska-Gadek, J.; Schmitz, M. L.; Ranftler, C. Roscovitine-activated HIP2 kinase induces phosphorylation of wt p53 at Ser-46 in human MCF-7 breast cancer cells. J. Cell. Biochem. 2007, 100, 865-874.
69. Choi, C. Y.; Kim, Y. H.; Kim, Y. O.; Park, S. J.; Kim, E. A.; Riemenschneider, W.; Gajewski, K.; Schulz, R. A.; Kim, Y. Phosphorylation by the DHIPK2 protein kinase modulates the corepressor activity of Groucho. J. Biol. Chem. 2005, 280, 21427-21436.
70. Mikkola, I.; Bruun, J. A.; Bjorkoy, G.; Holm, T.; Johansen, T. Phosphorylation of the transactivation domain of Pax6 by extracellular signal-regulated kinase and p38 mitogen-activated protein kinase. J. Biol. Chem. 1999, 274, 15115-15126.
71. Bulavin, D. V.; Saito, S.; Hollander, M. C.; Sakaguchi, K.; Anderson, C. W.; Appella, E.; Fornace, A. J., Jr. Phosphorylation of human p53 by p38 kinase coordinates N-terminal phosphorylation and apoptosis in response to UV radiation. EMBO J. 1999, 18, 6845-6854.
72. Yaffe, M. B.; Schutkowski, M.; Shen, M.; Zhou, X. Z.; Stukenberg, P. T.; Rahfeld, J. U.; Xu, J.; Kuang, J.; Kirschner, M. W.; Fischer, G.; Cantley, L. C.; Lu, K. P. Sequence-specific and phosphorylation-dependent proline isomerization: a potential mitotic regulatory mechanism. Science 1997, 278, 1957-1960.
73. Ranganathan, R.; Lu, K. P.; Hunter, T.; Noel, J. P. Structural and functional analysis of the mitotic rotamase Pin1 suggests substrate recognition is phosphorylation dependent. Cell 1997, 89, 875-886.
74. Yie, J.; Liang, S.; Merika, M.; Thanos, D. Intra- and intermolecular cooperative binding of high-mobility-group protein I(Y) to the beta-interferon promoter. Mol. Cell. Biol. 1997, 17, 3649-3662.
75. Frank, O.; Schwanbeck, R.; Wisniewski, J. R. Protein footprinting reveals specific binding modes of a high mobility group protein I to DNAs of different conformation. J. Biol. Chem. 1998, 273, 20015-20020.